Literature DB >> 28233015

[Endocrinology and interdisciplinary consultation in internal medicine : Illustrated using the example of polyglandular autoimmune syndrome].

G J Kahaly1, J Zimmermann2, M P Hansen2, F Gundling3, F Popp4, M Welcker4.   

Abstract

Polyglandular autoimmune syndromes encompass several endocrine and nonendocrine autoimmune disorders with variable onset and phenotype. Rheumatoid and gastroenterological symptoms in patients with autoimmune polyglandular syndromes are suggestive of additional rheumatoid gastrointestinal and hepatological autoimmune diseases. Autoimmune gastritis, celiac disease, autoimmune hepatitis, rheumatoid arthritis, Sjögren syndrome, and systemic Lupus erythematodus are of particular clinical relevance. In addition, unspecific rheumatoid and gastrointestinal attendant symptoms of the existing autoimmune endocrinopathy must be considered. Furthermore, certain disorders of polyglandular autoimmune syndromes, e. g., type 1 diabetes are frequently associated with particular gastrointestinal diseases such as small bowel bacterial overgrowth. An optimal patient-centered care of subjects with autoimmune diseases requires a comprehensive differential diagnostic work up and emphasizes the importance of an interdisciplinary cooperation.

Entities:  

Keywords:  Bone diseases; Celiac disease; Diabetes mellitus; Gastritis, atrophic; Rheumatic diseases

Mesh:

Year:  2017        PMID: 28233015     DOI: 10.1007/s00108-017-0201-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  77 in total

Review 1.  Autoimmune polyglandular syndrome type 1.

Authors:  P Obermayer-Straub; C P Strassburg; M P Manns
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice.

Authors:  M C van der Goes; J W G Jacobs; M Boers; T Andrews; M A M Blom-Bakkers; F Buttgereit; N Caeyers; M Cutolo; J A P Da Silva; L Guillevin; J R Kirwan; J Rovensky; G Severijns; S Webber; R Westhovens; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2010-08-06       Impact factor: 19.103

Review 3.  The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Ilaria Ruffilli; Giusy Elia; Marco Biricotti; Roberto Vita; Salvatore Benvenga; Alessandro Antonelli
Journal:  Autoimmun Rev       Date:  2016-09-15       Impact factor: 9.754

Review 4.  [Diagnostics and treatment of celiac disease].

Authors:  Andreas Stallmach; Detlef Schuppan
Journal:  Dtsch Med Wochenschr       Date:  2015-02-06       Impact factor: 0.628

Review 5.  The epidemiology of autoimmune diseases.

Authors:  Glinda S Cooper; Berrit C Stroehla
Journal:  Autoimmun Rev       Date:  2003-05       Impact factor: 9.754

Review 6.  The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy or autoimmune polyglandular syndrome type 1.

Authors:  Tim O Lankisch; Elmar Jaeckel; Christian P Strassburg
Journal:  Semin Liver Dis       Date:  2009-08-12       Impact factor: 6.115

Review 7.  Thyroid disorders and gastrointestinal and liver dysfunction: A state of the art review.

Authors:  Angelos Kyriacou; John McLaughlin; Akheel A Syed
Journal:  Eur J Intern Med       Date:  2015-08-08       Impact factor: 4.487

8.  [The polyglandular autoimmune syndrome--quality of life and family clustering].

Authors:  M P Hansen; S A M Wunderlich; S M Storz; N Matheis; M Knuf; G J Kahaly
Journal:  Dtsch Med Wochenschr       Date:  2014-09-09       Impact factor: 0.628

9.  Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects.

Authors:  P Enck; W Rathmann; M Spiekermann; D Czerner; D Tschöpe; D Ziegler; G Strohmeyer; F A Gries
Journal:  Z Gastroenterol       Date:  1994-11       Impact factor: 2.000

10.  HLA class II haplotypes differentiate between the adult autoimmune polyglandular syndrome types II and III.

Authors:  B K Flesch; N Matheis; T Alt; C Weinstock; J Bux; G J Kahaly
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.